SILLAJEN, INC.
Patent Owner
Stats
- 1 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 1 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 16 Total Citation Count
- Jan 04, 2012 Earliest Filing
- 0 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2015/0037,355 GENERATION OF ANTIBODIES TO TUMOR ANTIGENS AND GENERATION OF TUMOR SPECIFIC COMPLEMENT DEPENDENT CYTOTOXICITY BY ADMINISTRATION OF ONCOLYTIC VACCINIA VIRUSJan 04, 12Feb 05, 15[A61K, C12N, G01N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9919047 Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virusJan 04, 12Mar 20, 18[A61K, C12N, G01N, C07K]
Expired/Abandoned/Withdrawn Patents
- No Patents to Display
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.